Study identification

EU PAS number

EUPAS1000000899

Study ID

1000000899

Official title and acronym

Epidemiological study of epilepsy in France based on two databases (Epi²)

DARWIN EU® study

No

Study countries

France

Study description

The EPI² study is an epidemiological study based on the matching of health insurance data in France (Système National des Données de Santé, SNDS) and the Clinical Data Warehouse (CDW) of 39 hospital in Paris (Assistance Publique Hôpitaux de Paris, AP-HP). The objectives of this study are to validate an algorithm for identifying patients with epilepsy in the SNDS based on their healthcare consumption and using the clinical data from the AP-HP CDW as the gold standard, and then to use this algorithm to measure the incidence and prevalence of epilepsy in France. This study also aims to better understand the care pathways of epileptic patients and the associated costs.

Study status

Ongoing
Research institutions and networks

Institutions

Institut du Cerveau (Paris Brain Institute)

Contact details

Vincent Navarro

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of interim report, if expected

Planned:

Date of final study report

Planned:
Sources of funding
Other

More details on funding

DGOS
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable